Does every formulation of amphotericin B need to be diluted in 5% dextrose (D5W)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Amphotericin B Deoxycholate Require D5W Dilution?

Amphotericin B deoxycholate must be diluted in 5% dextrose (D5W) with pH above 4.2—this is an absolute requirement per FDA labeling, and saline solutions will cause precipitation of the drug. 1

Critical Preparation Requirements for Amphotericin B Deoxycholate

Mandatory D5W Dilution

The FDA-approved drug label explicitly states that amphotericin B deoxycholate:

  • Must be diluted in 5% Dextrose Injection USP with pH above 4.2 1
  • Cannot be reconstituted with saline solutions as this causes precipitation 1
  • Should achieve a final concentration of 0.1 mg/mL (diluted 1:50 from the initial 5 mg/mL concentrate) 1

pH Requirements

  • Check the pH of D5W before use—it must be above 4.2 1
  • Commercial D5W usually has pH above 4.2, but if below this threshold, add 1-2 mL of phosphate buffer 1
  • The recommended buffer composition is: dibasic sodium phosphate 1.59 g + monobasic sodium phosphate 0.96 g per 100 mL water 1

Volume Considerations

Use appropriate D5W volumes to prevent precipitation and filter blockage:

  • 25 mg/500 mL preparations frequently cause filter blockage and incomplete drug delivery (only 11.3% flows through) 2
  • Recommended preparations: 25 mg/250 mL or 50 mg/500 mL to ensure complete drug delivery and meet pharmacopeial standards 2
  • Avoid 25 mg/500 mL dilutions in clinical practice 2

Lipid Formulations: Different Rules

Liposomal amphotericin B and other lipid formulations have different dilution requirements:

  • Liposomal amphotericin B should be diluted in D5W (200 mL for 5 mg/kg dose) 3
  • Infusion time is shorter (2-3 hours vs 6-8 hours for deoxycholate) 3
  • These formulations are NOT interchangeable with amphotericin B deoxycholate 4

Clinical Guidelines Confirm D5W Requirement

Multiple authoritative guidelines consistently specify D5W for amphotericin B deoxycholate:

  • COVID-19 fungal infection guidelines: "Give in 5% dextrose with slow infusion over 6-8 h" 3
  • Leishmaniasis guidelines: "Dilute dose in D5W (∼50-100 mL) for IV" 5
  • Sporotrichosis guidelines: Amphotericin B deoxycholate dosing assumes D5W dilution 6

Common Pitfalls to Avoid

  1. Never use saline or bacteriostatic agents (e.g., benzyl alcohol)—these cause immediate precipitation 1
  2. Do not use D5W with pH below 4.2 without buffering 1
  3. Avoid excessive dilution (25 mg/500 mL) which causes filter blockage 2
  4. Do not confuse formulations: lipid preparations have different pharmacokinetics and cannot substitute for deoxycholate on a mg-per-mg basis 4, 7

Alternative Lipid Emulsion Dilution (Research Context)

While research studies have explored amphotericin B diluted in Intralipid (fat emulsion) showing reduced infusion reactions and potentially less nephrotoxicity 8, 9, 10, 11, this is not FDA-approved and the official drug label mandates D5W only 1. The lipid emulsion approach remains investigational and should not replace standard D5W preparation without institutional protocol approval.

References

Research

Influence of 5% dextrose volume on amphotericin B deoxycholate preparation.

The Journal of pharmacy and pharmacology, 2016

Guideline

guidelines for treatment of candidiasis.

Clinical Infectious Diseases, 2004

Research

Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.